Mark D. M. Leiserson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark D. M. Leiserson has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin J. Raphael
Department of Computer Science, Princeton University, Princeton, USA
15 shared publications - Alexander Upfill-Brown
Department of Orthopedics, Hospital for Special Surgery, New York, NY
14 shared publications - Antoni Ribas
Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, USA
14 shared publications - Brian B. Nadel
University of California, Los Angeles
14 shared publications - Brian H. Shirts
Department of Laboratory Medicine and Pathology, University of Washington
14 shared publications - Catherine J. Wu
Dana-Farber Cancer Institute
14 shared publications
Latest Publications
- Open Access
- 5 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (27) , eadj7402
Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes
The study of the tumor microbiome has been garnering increased attention. We developed a computational pipeline (CSI-Microbes) for identifying microbial reads from single-cell RNA sequencing (scRNA-seq) data and for analyzing differential abundance of taxa. Using a series of controlled experiments and analyses, we performed the first systematic evaluation of the efficacy of recovering microbial unique molecular identifiers by multiple scRNA-seq technologies, which identified the newer 10x chemistries (3′ v3 and 5′) as the best suited approach. We analyzed patient esophageal and colorectal carcinomas and found that reads from distinct genera tend to co-occur in the same host cells, testifying to possible intracellular polymicrobial interactions. Microbial reads are disproportionately abundant within myeloid cells that up-regulate proinflammatory cytokines like IL1 Β and CXCL8 , while infected tumor cells up-regulate antigen processing and presentation pathways. These results show that myeloid cells with bacteria engulfed are a major source of bacterial RNA within the tumor microenvironment (TME) and may inflame the TME and influence immunotherapy response.
- 5 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (27) , eadj7402
Open AccessIdentification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes
The study of the tumor microbiome has been garnering increased attention. We developed a computational pipeline (CSI-Microbes) for identifying microbial reads from single-cell RNA sequencing (scRNA-seq) data and for analyzing differential abundance of taxa. Using a series of controlled experiments and analyses, we performed the first systematic evaluation of the efficacy of recovering microbial unique molecular identifiers by multiple scRNA-seq technologies, which identified the newer 10x chemistries (3′ v3 and 5′) as the best suited approach. We analyzed patient esophageal and colorectal carcinomas and found that reads from distinct genera tend to co-occur in the same host cells, testifying to possible intracellular polymicrobial interactions. Microbial reads are disproportionately abundant within myeloid cells that up-regulate proinflammatory cytokines like IL1 Β and CXCL8 , while infected tumor cells up-regulate antigen processing and presentation pathways. These results show that myeloid cells with bacteria engulfed are a major source of bacterial RNA within the tumor microenvironment (TME) and may inflame the TME and influence immunotherapy response.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supp. Tables S1, S3-S15, S20, and S23 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupp. Tables S1, S3-S15, S20, and S23 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supp. Table S22 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupp. Table S22 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supp. Table S2 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupp. Table S2 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supp. Tables S16-S19 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Supplementary Tables S16-S19, describing IHC results on NHS/HPFS data
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupp. Tables S16-S19 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Supplementary Tables S16-S19, describing IHC results on NHS/HPFS data
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Data from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
To understand the genetic drivers of immune recognition and evasion in colorectal cancer, we analyzed 1,211 colorectal cancer primary tumor samples, including 179 classified as microsatellite instability–high (MSI-high). This set includes The Cancer Genome Atlas colorectal cancer cohort of 592 samples, completed and analyzed here. MSI-high, a hypermutated, immunogenic subtype of colorectal cancer, had a high rate of significantly mutated genes in important immune-modulating pathways and in the antigen presentation machinery, including biallelic losses of B2M and HLA genes due to copy-number alterations and copy-neutral loss of heterozygosity. WNT/β-catenin signaling genes were significantly mutated in all colorectal cancer subtypes, and activated WNT/β-catenin signaling was correlated with the absence of T-cell infiltration. This large-scale genomic analysis of colorectal cancer demonstrates that MSI-high cases frequently undergo an immunoediting process that provides them with genetic events allowing immune escape despite high mutational load and frequent lymphocytic infiltration and, furthermore, that colorectal cancer tumors have genetic and methylation events associated with activated WNT signaling and T-cell exclusion.Significance: This multi-omic analysis of 1,211 colorectal cancer primary tumors reveals that it should be possible to better monitor resistance in the 15% of cases that respond to immune blockade therapy and also to use WNT signaling inhibitors to reverse immune exclusion in the 85% of cases that currently do not. Cancer Discov; 8(6); 730–49. ©2018 AACR.This article is highlighted in the In This Issue feature, p. 663
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
To understand the genetic drivers of immune recognition and evasion in colorectal cancer, we analyzed 1,211 colorectal cancer primary tumor samples, including 179 classified as microsatellite instability–high (MSI-high). This set includes The Cancer Genome Atlas colorectal cancer cohort of 592 samples, completed and analyzed here. MSI-high, a hypermutated, immunogenic subtype of colorectal cancer, had a high rate of significantly mutated genes in important immune-modulating pathways and in the antigen presentation machinery, including biallelic losses of B2M and HLA genes due to copy-number alterations and copy-neutral loss of heterozygosity. WNT/β-catenin signaling genes were significantly mutated in all colorectal cancer subtypes, and activated WNT/β-catenin signaling was correlated with the absence of T-cell infiltration. This large-scale genomic analysis of colorectal cancer demonstrates that MSI-high cases frequently undergo an immunoediting process that provides them with genetic events allowing immune escape despite high mutational load and frequent lymphocytic infiltration and, furthermore, that colorectal cancer tumors have genetic and methylation events associated with activated WNT signaling and T-cell exclusion.Significance: This multi-omic analysis of 1,211 colorectal cancer primary tumors reveals that it should be possible to better monitor resistance in the 15% of cases that respond to immune blockade therapy and also to use WNT signaling inhibitors to reverse immune exclusion in the 85% of cases that currently do not. Cancer Discov; 8(6); 730–49. ©2018 AACR.This article is highlighted in the In This Issue feature, p. 663
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supp. Table S21 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Supplementary Table S21: Segmented copy-number ratios
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupp. Table S21 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Supplementary Table S21: Segmented copy-number ratios
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supp. Table S21 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupp. Table S21 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supp. Figures and Legends from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupp. Figures and Legends from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supp. Figures and Legends from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupp. Figures and Legends from Genetic Mechanisms of Immune Evasion in Colorectal Cancer